Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

109,303 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
High expression of vinculin predicts poor prognosis and distant metastasis and associates with influencing tumor-associated NK cell infiltration and epithelial-mesenchymal transition in gastric cancer.
Li H, Wang C, Lan L, Behrens A, Tomaschko M, Ruiz J, Su Q, Zhao G, Yuan C, Xiao X, Li B, Yan L, Wu W, Li W, Chen J, He Y, Zhang C. Li H, et al. Among authors: wang c. Aging (Albany NY). 2021 Feb 1;13(4):5197-5225. doi: 10.18632/aging.202440. Epub 2021 Feb 1. Aging (Albany NY). 2021. PMID: 33535187 Free PMC article.
Ethaselen synergizes with oxaliplatin in tumor growth inhibition by inducing ROS production and inhibiting TrxR1 activity in gastric cancer.
Zhang H, Wu J, Yuan J, Li H, Zhang Y, Wu W, Chen W, Wang C, Meng S, Chen S, Huo M, He Y, Zhang C. Zhang H, et al. Among authors: wang c. J Exp Clin Cancer Res. 2021 Aug 19;40(1):260. doi: 10.1186/s13046-021-02052-z. J Exp Clin Cancer Res. 2021. Retraction in: J Exp Clin Cancer Res. 2022 Feb 15;41(1):63. doi: 10.1186/s13046-022-02268-7 PMID: 34412665 Free PMC article. Retracted.
PARP1 Inhibitor Combined With Oxaliplatin Efficiently Suppresses Oxaliplatin Resistance in Gastric Cancer-Derived Organoids via Homologous Recombination and the Base Excision Repair Pathway.
Li H, Wang C, Lan L, Wu W, Evans I, Ruiz EJ, Yan L, Zhou Z, Oliveira JM, Reis RL, Hu Z, Chen W, Behrens A, He Y, Zhang C. Li H, et al. Among authors: wang c. Front Cell Dev Biol. 2021 Aug 23;9:719192. doi: 10.3389/fcell.2021.719192. eCollection 2021. Front Cell Dev Biol. 2021. PMID: 34497808 Free PMC article.
Retraction Note: Ethaselen synergizes with oxaliplatin in tumor growth inhibition by inducing ROS production and inhibiting TrxR1 activity in gastric cancer.
Zhang H, Wu J, Yuan J, Li H, Zhang Y, Wu W, Chen W, Wang C, Meng S, Chen S, Huo M, He Y, Zhang C. Zhang H, et al. Among authors: wang c. J Exp Clin Cancer Res. 2022 Feb 15;41(1):63. doi: 10.1186/s13046-022-02268-7. J Exp Clin Cancer Res. 2022. PMID: 35168643 Free PMC article. No abstract available.
109,303 results
You have reached the last available page of results. Please see the User Guide for more information.